Updated 02:01 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,876.40 -0.25% CL 88.33 -0.26% BTC 64,613.34 +0.76%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,876 −0.25% BTC $64,613 +0.76% VIX 19.30 +3.21% latest tape · as of 02:01 UTC
The Screen · Basic Materials · Chemicals

AdvanSix Inc

ASIX · the NYSE · USD · Market cap $423M · 1,410 employees

AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally.

Not yet scored
15.68 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price15.68 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenNot yet scored
  • OptionsOpen interest leans to puts (put/call 1.40)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $16.20 to $20.32, base estimate $17.67 (screen dated 2026-11-13).

Current read
Distribution ?
Undervalued · screened 2026-11-13
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 1.40, read 2026-11-15
  • Ethical screen not yet scored
Price15.68 USD
Fair value17.67
Ethical score70.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-09-24Read Markdown16.25-3.5% to today ✓Distribution gives way to Markdown first Markdown read since July
2026-08-22Read Distribution16.53-5.1% to today ✓Markdown gives way to Distribution after a 20% slide in 5 weeks
2026-07-21Read Markdown20.79-24.6% to today ✓Distribution gives way to Markdown after a 9% slide in 3 weeks
2026-07-02Read Distribution22.81-31.3% to today ✓First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

AdvanSix Inc holds its Distribution at $15.68. Consolidating, no directional conviction, held for 48 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 48 days
Price at the screen$15.68
ValuationN/A trailing · 6.57 forward price to earnings
Values screenNot scored · score 70.0
Beta1.34
The Workings

Five Screens, Shown in Full

This security has not been fully scored against the values screen yet.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 22.30% Below 33% Interest-bearing debt is just 22.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 10.13% Below 49% Money owed to the company is 10.1% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

The Read, in Plain English

AdvanSix clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

2026-10-25

AdvanSix clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.

2026-09-24 Clears

AdvanSix clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 22%, inside the ~33% line, and almost none of its income is interest, so it passes.

Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly an 11% discount to our $17.67 fair value, none competitive moat, 2.70% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

16.20Conservative17.67Base case20.32Growth case 15.68Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 11.3% discount to the base estimate.

The Street's Range
18.00Street low 20.00Street average 22.00Street high 15.68Price

Third-party analyst targets. The average target sits +28% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $17.67, with a range of $16.20 to $20.32, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it stands out

A 3%-growth business trading at just 6.6x forward earnings, with a none competitive moat. That is an 11% discount to our $17.67 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.

The fundamentals · plain-English read
Forward P/E6.6xexpensive even after accounting for its growth
EPS, trailing-0.67
EPS, forward2.39
Revenue growth+2.7%slow but positive growth
Profit margin-1.1%currently unprofitable
Return on equity-2.2%not currently earning a positive return on equity
FCF yield-3.34%
Dividend yield3.22%
Debt to equity0.53moderate, manageable leverage
Current ratio1.28adequate liquidity, worth monitoring
Beta1.34moves a little more than the market
Short interest, float0.02%
52-week range14.10 - 26.73
MoatNONE
Market cap$423M
Employees1,410

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

ASIX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-10 Markdown $15.63 +1.8% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-11-03 Markdown $15.36 -2.0% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-10-27 Markdown $15.68 -5.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-10-20 Markdown $16.50 +1.6% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-10-13 Markdown $16.24 -0.1% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-10-02 Markdown $16.25 +0.0% Entry 8

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-09-24 Markdown · changed $16.25 -1.7% Entry 7

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-08-22 Distribution · changed $16.53 -20.5% Entry 6

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-07-21 Markdown · changed $20.79 -8.9% Entry 5

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

2026-07-18 Distribution $22.81 +0.0% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 14% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (2 analysts) rates it buy, with a mean price target of $24.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on ASIX

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in ASIX's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $22.36 -4.0% $0.16 $968 -3.2%
2 months $23.76 -9.6% $0.16 $911 -8.9%
3 months $20.84 +3.1% $0.16 $1,039 +3.9%
6 months $16.44 +30.6% $0.32 $1,326 +32.6%
1 year $23.74 -9.5% $0.64 $932 -6.8%
2 years $22.37 -4.0% $1.28 $1,018 +1.8%
3 years $32.71 -34.3% $1.92 $715 -28.5%
5 years $27.55 -22.0% $2.88 $884 -11.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever ASIX does next, these words stay.

AdvanSix Inc · ASIX · Distribution · $15.68
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.